000783:SZSEChangjiang Securities Company Limited Analysis
Data as of 2026-08-01 - not real-time
CN¥8.60
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Changjiang Securities is trading in a bullish technical environment, with the 20‑day SMA (≈8.78) comfortably above the 50‑day (≈8.60) and 200‑day (≈8.20) averages, and the price (8.6) sitting above the identified support of 8.24. However, the MACD has turned bearish, volume is on a downtrend, and the 30‑day volatility is elevated (≈73%), suggesting short‑term pressure. The stock is cheap on a valuation basis – its trailing P/E (~12) is well below the sector average (~18) and the P/B (~1.3) is modest – while delivering an attractive dividend yield of 3.5% with a low payout ratio (~20%).
Fundamentally, revenue surged 34% YoY and margins remain robust (gross >50%, operating >56%), backed by a massive cash pile (>CNY 111 bn). Nevertheless, the balance sheet is leveraged (debt‑to‑equity >160%) and the forward P/E jumps to ~25, tempering optimism. Analysts are neutral (hold) and the market sentiment is in “Extreme Greed” territory, implying that any upside may be limited to the modest 4‑5% upside indicated by consensus targets.
Fundamentally, revenue surged 34% YoY and margins remain robust (gross >50%, operating >56%), backed by a massive cash pile (>CNY 111 bn). Nevertheless, the balance sheet is leveraged (debt‑to‑equity >160%) and the forward P/E jumps to ~25, tempering optimism. Analysts are neutral (hold) and the market sentiment is in “Extreme Greed” territory, implying that any upside may be limited to the modest 4‑5% upside indicated by consensus targets.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD divergence
- Decreasing trading volume
- Price hovering just above recent support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high operating margins
- Attractive dividend yield with low payout ratio
- Valuation discount relative to industry peers
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained cash generation and dividend sustainability
- Elevated leverage and potential regulatory headwinds
- Moderate upside potential reflected in analyst price targets
Key Metrics & Analysis
Financial Health
Revenue Growth34.60%
Profit Margin36.99%
P/E Ratio11.9
ROE10.11%
ROA2.33%
Debt/Equity160.13
P/B Ratio1.3
Op. Cash FlowCN¥12.2B
Industry P/E18.0
Technical Analysis
TrendBullish
RSI47.7
SupportCN¥8.24
ResistanceCN¥10.18
MA 20CN¥8.78
MA 50CN¥8.60
MA 200CN¥8.20
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Fair ValueCN¥61.71
Target PriceCN¥9.01
Upside/Downside4.77%
GradeUndervalued
TypeBlend
Dividend Yield3.49%
Risk Assessment
Beta0.44
Volatility73.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.